» Articles » PMID: 28538878

Hidradenitis Suppurativa: Epidemiological Study of Cases Diagnosed at a Dermatological Reference Center in the City of Bauru, in the Brazilian Southeast State of São Paulo, Between 2005 and 2015

Overview
Specialty Dermatology
Date 2017 May 25
PMID 28538878
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background:: Hidradenitis is a chronic inflammatory disease of the hair follicles. A treatment is necessary due to chronicity and psychological changes that patient present.

Objective:: To investigate epidemiological aspects and elaborate a risk group profile, promote early diagnosis and contribute to the knowledge about the disease.

Methods:: This cross-sectional descriptive study with retrospective analysis of medical records of 194 patients diagnosed with hidrosadenitis in a dermatological reference center in the city of Bauru (SP) between 2005 and 2015.

Results:: Females accounted for 74% of cases. The age at diagnosis ranged from 10 to 67 years and the majority was within the 3rd and 4th decade of life. It occurred Association with diabetes mellitus in 33%, obesity in 55% and smoking in 61% was observed. Mean time between the onset of the disease and diagnosis was nine years. Hurley stage II was the most common at diagnosis. The therapeutic option mostly used in Hurley I and II was systemic antibiotics and in Hurley III was surgery.

Study Limitations:: the main limitation of this study is its retrospective design, which does not allow the true clinical confirmation of the disease by investigators.

Conclusion:: we outlined the following profile: women, caucasian, between 3rd and 4th decade of life, associated with obesity, smoking, late diagnosis and multiple potential therapeutic modalities. We highlight the importance of studies like this in order to identify risk groups and encourage early diagnosis.

Citing Articles

Uncovering the burden of hidradenitis suppurativa misdiagnosis and underdiagnosis: a machine learning approach.

Kirby J, Kim K, Zivkovic M, Wang S, Garg V, Danavar A Front Med Technol. 2024; 6:1200400.

PMID: 38591045 PMC: 10999681. DOI: 10.3389/fmedt.2024.1200400.


Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms.

Bellei E, de Carvalho A, Eng B, Tozato C, de Barros D, Tamashiro E Dermatol Ther (Heidelb). 2023; 13(11):2797-2815.

PMID: 37794274 PMC: 10613171. DOI: 10.1007/s13555-023-01032-9.


Prevalence of low vitamin D levels in patients with Hidradenitis suppurativa in Jordan: A comparative cross-sectional study.

Seetan K, Eldos B, Saraireh M, Omari R, Rubbai Y, Jayyusi A PLoS One. 2022; 17(3):e0265672.

PMID: 35303020 PMC: 8932615. DOI: 10.1371/journal.pone.0265672.


Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil.

Rivitti-Machado M, Magalhaes R, da Silva R, Duarte G, Bosnich F, Tunala R Drugs Context. 2022; 11.

PMID: 35145556 PMC: 8798365. DOI: 10.7573/dic.2021-9-6.


Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Tavora I, Bissoli G, Miot H, Schmitt J An Bras Dermatol. 2019; 94(3):298-303.

PMID: 31365658 PMC: 6668954. DOI: 10.1590/abd1806-4841.20197687.

References
1.
Vlassova N, Kuhn D, A Okoye G . Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis. Acta Derm Venereol. 2015; 95(8):990-1. DOI: 10.2340/00015555-2176. View

2.
Mehdizadeh A, Hazen P, Bechara F, Zwingerman N, Moazenzadeh M, Bashash M . Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis. J Am Acad Dermatol. 2015; 73(5 Suppl 1):S70-7. DOI: 10.1016/j.jaad.2015.07.044. View

3.
Schmitt J, Bombonatto G, Martin M, Miot H . Risk factors for hidradenitis suppurativa: a pilot study. An Bras Dermatol. 2012; 87(6):936-8. PMC: 3699910. DOI: 10.1590/s0365-05962012000600024. View

4.
Scheinfeld N . Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis. Dermatol Online J. 2013; 19(6):18558. View

5.
Shlyankevich J, Chen A, Kim G, Kimball A . Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. J Am Acad Dermatol. 2014; 71(6):1144-50. DOI: 10.1016/j.jaad.2014.09.012. View